Product
Glecaprevir/pibrentasvir
Aliases
Mavyret
3 clinical trials
3 indications
Indication
End-Stage Renal DiseaseIndication
Hepatitis CIndication
PTSDClinical trial
An Open-label, Non-randomized Pilot Study to Determine the Safety and Efficacy of Two Weeks of Fixed-dose Glecaprevir and Pibrentasvir as Pre- and Post-exposure Prophylactic TherapyStatus: Completed, Estimated PCD: 2023-11-28
Clinical trial
A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney TransplantationStatus: Active (not recruiting), Estimated PCD: 2023-05-16
Clinical trial
Randomized Controlled Trial of Glecaprevir/Pibrentasvir for the Treatment of Post-traumatic Stress DisorderStatus: Not yet recruiting, Estimated PCD: 2025-12-31